These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


269 related items for PubMed ID: 18723960

  • 1. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in diabetic foot infections.
    Varaiya AY, Dogra JD, Kulkarni MH, Bhalekar PN.
    Indian J Pathol Microbiol; 2008; 51(3):370-2. PubMed ID: 18723960
    [Abstract] [Full Text] [Related]

  • 2. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Kuzucu C, Yetkin F, Görgeç S, Ersoy Y.
    Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
    [Abstract] [Full Text] [Related]

  • 3. Nosocomial blood-stream infections from extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumonia from GB Pant Hospital, New Delhi.
    Taneja J, Mishra B, Thakur A, Dogra V, Loomba P.
    J Infect Dev Ctries; 2010 Sep 03; 4(8):517-20. PubMed ID: 20818104
    [Abstract] [Full Text] [Related]

  • 4. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K, Wong SS, Lin LC, Tsai CR, Chen LC, Huang CH.
    J Microbiol Immunol Infect; 2012 Jun 03; 45(3):193-9. PubMed ID: 22580086
    [Abstract] [Full Text] [Related]

  • 5. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
    Del Carmen Rodríguez M, Vera DE, Ramírez-Ronda CH, Saavedra S.
    P R Health Sci J; 2004 Sep 03; 23(3):207-15. PubMed ID: 15631176
    [Abstract] [Full Text] [Related]

  • 6. Extended spectrum beta lactamase (ESBL) producing Escherichia coli and klebsiella pneumoniae in diabetic foot infection.
    Varaiya A, Dogra J, Kulkarni M, Bhalekar P.
    Indian J Med Microbiol; 2008 Sep 03; 26(3):281-2. PubMed ID: 18695337
    [No Abstract] [Full Text] [Related]

  • 7. Extended spectrum beta-lactamase and metallo beta-lactamase production among Escherichia coli and Klebsiella pneumoniae isolated from different clinical samples in a tertiary care hospital in Kathmandu, Nepal.
    Nepal K, Pant ND, Neupane B, Belbase A, Baidhya R, Shrestha RK, Lekhak B, Bhatta DR, Jha B.
    Ann Clin Microbiol Antimicrob; 2017 Sep 19; 16(1):62. PubMed ID: 28927454
    [Abstract] [Full Text] [Related]

  • 8. Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings.
    Khanfar HS, Bindayna KM, Senok AC, Botta GA.
    J Infect Dev Ctries; 2009 May 01; 3(4):295-9. PubMed ID: 19759493
    [Abstract] [Full Text] [Related]

  • 9. ESBL-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care hospital in Saudi Arabia.
    Somily AM, Habib HA, Absar MM, Arshad MZ, Manneh K, Al Subaie SS, Al Hedaithy MA, Sayyed SB, Shakoor Z, Murray TS.
    J Infect Dev Ctries; 2014 Sep 12; 8(9):1129-36. PubMed ID: 25212077
    [Abstract] [Full Text] [Related]

  • 10. Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital.
    Kader AA, Kumar A.
    Ann Saudi Med; 2005 Sep 12; 25(3):239-42. PubMed ID: 16119526
    [Abstract] [Full Text] [Related]

  • 11. Molecular characteristics of extended spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae and the prevalence of qnr in Extended spectrum beta-lactamase isolates in a tertiary care hospital in Korea.
    Kim MH, Lee HJ, Park KS, Suh JT.
    Yonsei Med J; 2010 Sep 12; 51(5):768-74. PubMed ID: 20635454
    [Abstract] [Full Text] [Related]

  • 12. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital.
    Basak S, Mallick SK, Bose S.
    J Indian Med Assoc; 2009 Dec 12; 107(12):855-8. PubMed ID: 20509468
    [Abstract] [Full Text] [Related]

  • 13. [Prevalence of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae from Daejeon].
    Ko CS, Sung JY, Koo SH, Kwon GC, Shin SY, Park JW.
    Korean J Lab Med; 2007 Oct 12; 27(5):344-50. PubMed ID: 18094599
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of extended-spectrum beta-lactamases among Escherichia coli and Klebsiella pneumoniae isolates in a tertiary care hospital.
    Agrawal P, Ghosh AN, Kumar S, Basu B, Kapila K.
    Indian J Pathol Microbiol; 2008 Oct 12; 51(1):139-42. PubMed ID: 18417887
    [Abstract] [Full Text] [Related]

  • 15. Epidemiology and antimicrobial susceptibility profiles of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichiacoli in China.
    Wang Y, Zhang Q, Jin Y, Jin X, Yu J, Wang K.
    Braz J Microbiol; 2019 Jul 12; 50(3):669-675. PubMed ID: 30972583
    [Abstract] [Full Text] [Related]

  • 16. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
    Duttaroy B, Mehta S.
    Indian J Pathol Microbiol; 2005 Jan 12; 48(1):45-8. PubMed ID: 16758790
    [Abstract] [Full Text] [Related]

  • 17. Dramatic rise in the proportion of ESBL-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates identified in Canadian hospital laboratories from 2007 to 2016.
    Denisuik AJ, Karlowsky JA, Adam HJ, Baxter MR, Lagacé-Wiens PRS, Mulvey MR, Hoban DJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA) and CANWARD.
    J Antimicrob Chemother; 2019 Aug 01; 74(Suppl 4):iv64-iv71. PubMed ID: 31505647
    [Abstract] [Full Text] [Related]

  • 18. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
    Xiong Z, Zhu D, Zhang Y, Wang F.
    Zhonghua Yi Xue Za Zhi; 2002 Nov 10; 82(21):1476-9. PubMed ID: 12509910
    [Abstract] [Full Text] [Related]

  • 19. CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.
    Martinez P, Garzón D, Mattar S.
    Braz J Infect Dis; 2012 Nov 10; 16(5):420-5. PubMed ID: 22964287
    [Abstract] [Full Text] [Related]

  • 20. Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.
    Zhang H, Yang Q, Liao K, Ni Y, Yu Y, Hu B, Sun Z, Huang W, Wang Y, Wu A, Feng X, Luo Y, Chu Y, Chen S, Cao B, Su J, Duan Q, Zhang S, Shao H, Kong H, Gui B, Hu Z, Badal R, Xu Y.
    BMC Infect Dis; 2017 Dec 18; 17(1):776. PubMed ID: 29254478
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.